CD8A and glioblastoma: These findings suggest that the that survival may be enhanced by increasing proliferation of tumor-infiltrating CD8+ T cells, and that approaches should be designed to promote CD8+ T cell dominance in GBM, and potentially mitigate or modify the immunoregulatory effects of IFNγ in the tumor microenvironment.